Statistics
Publications
1
Citations
148
H-Index
1
Active since
2024
Affiliations
Nurix (United States)(Current)
Y. Tan is an author at Nurix (United States) specializing in b cell biology, molecular oncology, and chronic lymphocytic leukemia therapy.
Publications per year
2024–2024
1
1
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text
1–1 of 1